Literature DB >> 6893172

HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.

B A Mather, D F Roberts, M F Scanlon, E D Mukhtar, T F Davies, B R Smith, R Hall.   

Abstract

Patients with Graves' disease (n = 105) had an increased frequency of HLA-B8 (40%) and a reduced frequency of HLA-B12 (24.8%) when compared with random controls (n = 117; 24.8% and 40.2% respectively). Comparison of patients with their first degree relatives (n = 118) shows the frequency deviations in these antigens to be characteristic of the families from which patients with Graves' disease are drawn, rather than of the disease itself. The haplotypes, identified in eight-six patients and 113 relatives, indicate that the excess of HLA-B8 in patients and their relatives is primarily due to the halpotype 1-8. The relative risk for an HLA-B8 individual of developing Graves' disease is 2.02, whilst the relative risk for an individual of haplotype 1-8 is 4.23. No significant associations were found between the incidence of any HLA antigen or combination thereof and the presence or absence of thyroglobulin and thyroid microsomal antibodies, or antibodies which interact with the TSH receptor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893172     DOI: 10.1111/j.1365-2265.1980.tb02130.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Immunogenetic markers in patients with Graves' disease.

Authors:  E Schifferdecker; P Kühnl; K Schöffling; B Manfras; G Holzberger; W Spielmann; B O Böhm
Journal:  Klin Wochenschr       Date:  1991-04-04

2.  Pathogenesis of autoimmune thyroid disease: some facts and some speculation.

Authors:  C R Strakosch; J R Wal
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

3.  Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

Authors:  Yaron Tomer; Yoshiyuki Ban; Erlinda Concepcion; Giuseppe Barbesino; Ronald Villanueva; David A Greenberg; Terry F Davies
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

4.  Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease.

Authors:  Yoshiyuki Ban; David A Greenberg; Erlinda Concepcion; Lucy Skrabanek; Ronald Villanueva; Yaron Tomer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

5.  A new Graves disease-susceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease.

Authors:  Y Tomer; G Barbesino; D A Greenberg; E Concepcion; T F Davies
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

6.  HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).

Authors:  C Papasteriades; M N Alevizaki-Harhalaki; J Economidou; D G Ikkos
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

Review 7.  [Genetics of thyroid autoimmunity - update and clinical relevance].

Authors:  Georg Dultz; Manuela Dittmar; George J Kahaly
Journal:  Med Klin (Munich)       Date:  2009-04-01

8.  'Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease.

Authors:  Yoshiyuki Ban; David A Greenberg; Terry F Davies; Eric Jacobson; Erlinda Concepcion; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

9.  Human lymphocyte antigens (HLA) and Graves' disease in Turkey.

Authors:  Y Orhan; A Azezli; M Carin; F Aral; E Sencer; S Molvalilar
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

Review 10.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.